Enalapril Viatris 5 mg comprimidos EFG
Sponsors
Oslo University Hospital HF, Region Skane
Conditions
C3 glomerulopathyVenous malformation
Phase 2
A single center, single arm, Phase 2, pilot study to investigate the efficacy of an angiotensin-converting enzyme inhibitor (ACE-inhibitor) in male and female participants aged 18-70 years of age with painful venous malformations.
RecruitingCTIS2023-510076-31-00
Start: 2025-01-30Target: 10Updated: 2024-12-17
Phase 2, multicenter, randomized, open-label, controlled, 2-arm cross-over study to evaluate the clinical efficacy and safety of a renin inhibitor, aliskiren, compared to an angiotensin converting enzyme inhibitor, enalapril, in children and adults with C3 glomerulopathy
RecruitingCTIS2024-515892-36-00
Start: 2020-01-01Target: 30Updated: 2024-07-10